Global Biosimilars Market 2024-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	180 Pages	TechNavio	August, 2024	INF19178798

Best Price Guarantee
Price	from $2,500
Length	180 Pages
Publisher	TechNavio
Published Date	August, 2024
SKU	INF19178798

Global Biosimilars Market 2024-2028

Biosimilars Market 2024-2028

The biosimilars market is forecasted to grow by USD 54353.3 mn during 2023-2028, accelerating at a CAGR of 23.63% during the forecast period. The report on the biosimilars market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by price advantage of biosimilars over biologics, patent expiry of major biologics, and government initiatives to increase use of biosimilar medicines.

Technavio's biosimilars market is segmented as below:

By Product Type

Monoclonal antibodies
Insulin
Human growth hormone
Others

By Application

Oncology and hematology
Endocrinology
Immunology
Nephrology

By Geographical Landscape

Europe
North America
Asia
Rest of World (ROW)

This study identifies the patients and physician's willingness to switch to biosimilars as one of the prime reasons driving the biosimilars market growth during the next few years. Also, therapeutic interchangeability regulations for biosimilars across countries and biosimilar's patent dance will lead to sizable demand in the market.

The report on the biosimilars market covers the following areas:

Biosimilars market sizing
Biosimilars market forecast
Biosimilars market industry analysis

The vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading biosimilars market vendors that include AbbVie Inc., Amgen Inc., Biocon Ltd., Biogen Inc., Boehringer Ingelheim International GmbH, Celltrion Healthcare Co. Ltd., DR Reddys Laboratories Ltd., F. Hoffmann La Roche Ltd., Fresenius SE and Co. KGaA, Gedeon Richter PLC, Halozyme Therapeutics Inc., Intas Pharmaceuticals Ltd., Mabion S.A., Novartis AG, Pfizer Inc., Samsung Biologics Co. Ltd., Sanofi SA, Teva Pharmaceutical Industries Ltd., and Viatris Inc.. Also, the biosimilars market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary: 1.1 Market overview; Executive Summary - Chart on Market Overview; Executive Summary - Data Table on Market Overview; Executive Summary - Chart on Global Market Characteristics; Executive Summary - Chart on Market By Geographical Landscape; Executive Summary - Chart on Market Segmentation by Product Type; Executive Summary - Chart on Market Segmentation by Application; Executive Summary - Chart on Incremental Growth; Executive Summary - Data Table on Incremental Growth; Executive Summary - Chart on Company Market Positioning
2 Market Landscape: 2.1 Market ecosystem; Parent Market; Data Table on - Parent Market; 2.2 Market characteristics; Market characteristics analysis; 2.3 Value chain analysis; Value Chain Analysis
3 Market Sizing: 3.1 Market definition; Offerings of companies included in the market definition; 3.2 Market segment analysis; Market segments; 3.3 Market size 2023; 3.4 Market outlook: Forecast for 2023-2028; Chart on Global - Market size and forecast 2023-2028 ($ million); Data Table on Global - Market size and forecast 2023-2028 ($ million); Chart on Global Market: Year-over-year growth 2023-2028 (%); Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size: 4.1 Global Biosimilars Market 2018 - 2022; Historic Market Size - Data Table on Global Biosimilars Market 2018 - 2022 ($ million); 4.2 Product Type segment analysis 2018 - 2022; Historic Market Size - Product Type Segment 2018 - 2022 ($ million); 4.3 Application segment analysis 2018 - 2022; Historic Market Size - Application Segment 2018 - 2022 ($ million); 4.4 Geography segment analysis 2018 - 2022; Historic Market Size - Geography Segment 2018 - 2022 ($ million); 4.5 Country segment analysis 2018 - 2022; Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis: 5.1 Five forces summary; Five forces analysis - Comparison between 2023 and 2028; 5.2 Bargaining power of buyers; Bargaining power of buyers - Impact of key factors 2023 and 2028; 5.3 Bargaining power of suppliers; Bargaining power of suppliers - Impact of key factors in 2023 and 2028; 5.4 Threat of new entrants; Threat of new entrants - Impact of key factors in 2023 and 2028; 5.5 Threat of substitutes; Threat of substitutes - Impact of key factors in 2023 and 2028; 5.6 Threat of rivalry; Threat of rivalry - Impact of key factors in 2023 and 2028; 5.7 Market condition; Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Product Type: 6.1 Market segments; Chart on Product Type - Market share 2023-2028 (%); Data Table on Product Type - Market share 2023-2028 (%); 6.2 Comparison by Product Type; Chart on Comparison by Product Type; Data Table on Comparison by Product Type; 6.3 Monoclonal antibodies - Market size and forecast 2023-2028; Chart on Monoclonal antibodies - Market size and forecast 2023-2028 ($ million); Data Table on Monoclonal antibodies - Market size and forecast 2023-2028 ($ million); Chart on Monoclonal antibodies - Year-over-year growth 2023-2028 (%); Data Table on Monoclonal antibodies - Year-over-year growth 2023-2028 (%); 6.4 Insulin - Market size and forecast 2023-2028; Chart on Insulin - Market size and forecast 2023-2028 ($ million); Data Table on Insulin - Market size and forecast 2023-2028 ($ million); Chart on Insulin - Year-over-year growth 2023-2028 (%); Data Table on Insulin - Year-over-year growth 2023-2028 (%); 6.5 Human growth hormone - Market size and forecast 2023-2028; Chart on Human growth hormone - Market size and forecast 2023-2028 ($ million); Data Table on Human growth hormone - Market size and forecast 2023-2028 ($ million); Chart on Human growth hormone - Year-over-year growth 2023-2028 (%); Data Table on Human growth hormone - Year-over-year growth 2023-2028 (%); 6.6 Others - Market size and forecast 2023-2028; Chart on Others - Market size and forecast 2023-2028 ($ million); Data Table on Others - Market size and forecast 2023-2028 ($ million); Chart on Others - Year-over-year growth 2023-2028 (%); Data Table on Others - Year-over-year growth 2023-2028 (%); 6.7 Market opportunity by Product Type; Market opportunity by Product Type ($ million); Data Table on Market opportunity by Product Type ($ million)
7 Market Segmentation by Application: 7.1 Market segments; Chart on Application - Market share 2023-2028 (%); Data Table on Application - Market share 2023-2028 (%); 7.2 Comparison by Application; Chart on Comparison by Application; Data Table on Comparison by Application; 7.3 Oncology and hematology - Market size and forecast 2023-2028; Chart on Oncology and hematology - Market size and forecast 2023-2028 ($ million); Data Table on Oncology and hematology - Market size and forecast 2023-2028 ($ million); Chart on Oncology and hematology - Year-over-year growth 2023-2028 (%); Data Table on Oncology and hematology - Year-over-year growth 2023-2028 (%); 7.4 Endocrinology - Market size and forecast 2023-2028; Chart on Endocrinology - Market size and forecast 2023-2028 ($ million); Data Table on Endocrinology - Market size and forecast 2023-2028 ($ million); Chart on Endocrinology - Year-over-year growth 2023-2028 (%); Data Table on Endocrinology - Year-over-year growth 2023-2028 (%); 7.5 Immunology - Market size and forecast 2023-2028; Chart on Immunology - Market size and forecast 2023-2028 ($ million); Data Table on Immunology - Market size and forecast 2023-2028 ($ million); Chart on Immunology - Year-over-year growth 2023-2028 (%); Data Table on Immunology - Year-over-year growth 2023-2028 (%); 7.6 Nephrology - Market size and forecast 2023-2028; Chart on Nephrology - Market size and forecast 2023-2028 ($ million); Data Table on Nephrology - Market size and forecast 2023-2028 ($ million); Chart on Nephrology - Year-over-year growth 2023-2028 (%); Data Table on Nephrology - Year-over-year growth 2023-2028 (%); 7.7 Market opportunity by Application; Market opportunity by Application ($ million); Data Table on Market opportunity by Application ($ million)
8 Customer Landscape: 8.1 Customer landscape overview; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape: 9.1 Geographic segmentation; Chart on Market share By Geographical Landscape 2023-2028 (%); Data Table on Market share By Geographical Landscape 2023-2028 (%); 9.2 Geographic comparison; Chart on Geographic comparison; Data Table on Geographic comparison; 9.3 Europe - Market size and forecast 2023-2028; Chart on Europe - Market size and forecast 2023-2028 ($ million); Data Table on Europe - Market size and forecast 2023-2028 ($ million); Chart on Europe - Year-over-year growth 2023-2028 (%); Data Table on Europe - Year-over-year growth 2023-2028 (%); 9.4 North America - Market size and forecast 2023-2028; Chart on North America - Market size and forecast 2023-2028 ($ million); Data Table on North America - Market size and forecast 2023-2028 ($ million); Chart on North America - Year-over-year growth 2023-2028 (%); Data Table on North America - Year-over-year growth 2023-2028 (%); 9.5 Asia - Market size and forecast 2023-2028; Chart on Asia - Market size and forecast 2023-2028 ($ million); Data Table on Asia - Market size and forecast 2023-2028 ($ million); Chart on Asia - Year-over-year growth 2023-2028 (%); Data Table on Asia - Year-over-year growth 2023-2028 (%); 9.6 Rest of World (ROW) - Market size and forecast 2023-2028; Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); 9.7 Germany - Market size and forecast 2023-2028; Chart on Germany - Market size and forecast 2023-2028 ($ million); Data Table on Germany - Market size and forecast 2023-2028 ($ million); Chart on Germany - Year-over-year growth 2023-2028 (%); Data Table on Germany - Year-over-year growth 2023-2028 (%); 9.8 US - Market size and forecast 2023-2028; Chart on US - Market size and forecast 2023-2028 ($ million); Data Table on US - Market size and forecast 2023-2028 ($ million); Chart on US - Year-over-year growth 2023-2028 (%); Data Table on US - Year-over-year growth 2023-2028 (%); 9.9 UK - Market size and forecast 2023-2028; Chart on UK - Market size and forecast 2023-2028 ($ million); Data Table on UK - Market size and forecast 2023-2028 ($ million); Chart on UK - Year-over-year growth 2023-2028 (%); Data Table on UK - Year-over-year growth 2023-2028 (%); 9.10 China - Market size and forecast 2023-2028; Chart on China - Market size and forecast 2023-2028 ($ million); Data Table on China - Market size and forecast 2023-2028 ($ million); Chart on China - Year-over-year growth 2023-2028 (%); Data Table on China - Year-over-year growth 2023-2028 (%); 9.11 Republic of Korea - Market size and forecast 2023-2028; Chart on Republic of Korea - Market size and forecast 2023-2028 ($ million); Data Table on Republic of Korea - Market size and forecast 2023-2028 ($ million); Chart on Republic of Korea - Year-over-year growth 2023-2028 (%); Data Table on Republic of Korea - Year-over-year growth 2023-2028 (%); 9.12 Market opportunity By Geographical Landscape; Market opportunity By Geographical Landscape ($ million); Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Opportunity/Restraints: 10.1 Market drivers; 10.2 Market challenges; 10.3 Impact of drivers and challenges; Impact of drivers and challenges in 2023 and 2028; 10.4 Market opportunities/restraints
11 Competitive Landscape: 11.1 Overview; 11.2 Competitive Landscape; Overview on criticality of inputs and factors of differentiation; 11.3 Landscape disruption; Overview on factors of disruption; 11.4 Industry risks; Impact of key risks on business
12 Competitive Analysis: 12.1 Companies profiled; Companies covered; 12.2 Market positioning of companies; Matrix on companies position and classification; 12.3 AbbVie Inc.; AbbVie Inc. - Overview; AbbVie Inc. - Product / Service; AbbVie Inc. - Key news; AbbVie Inc. - Key offerings; 12.4 Amgen Inc.; Amgen Inc. - Overview; Amgen Inc. - Product / Service; Amgen Inc. - Key news; Amgen Inc. - Key offerings; 12.5 Biocon Ltd.; Biocon Ltd. - Overview; Biocon Ltd. - Business segments; Biocon Ltd. - Key offerings; Biocon Ltd. - Segment focus; 12.6 Biogen Inc.; Biogen Inc. - Overview; Biogen Inc. - Product / Service; Biogen Inc. - Key news; Biogen Inc. - Key offerings; 12.7 Boehringer Ingelheim International GmbH; Boehringer Ingelheim International GmbH - Overview; Boehringer Ingelheim International GmbH - Product / Service; Boehringer Ingelheim International GmbH - Key news; Boehringer Ingelheim International GmbH - Key offerings; 12.8 Celltrion Healthcare Co. Ltd.; Celltrion Healthcare Co. Ltd. - Overview; Celltrion Healthcare Co. Ltd. - Product / Service; Celltrion Healthcare Co. Ltd. - Key offerings; 12.9 Dr Reddys Laboratories Ltd.; Dr Reddys Laboratories Ltd. - Overview; Dr Reddys Laboratories Ltd. - Business segments; Dr Reddys Laboratories Ltd. - Key news; Dr Reddys Laboratories Ltd. - Key offerings; Dr Reddys Laboratories Ltd. - Segment focus; 12.10 F. Hoffmann La Roche Ltd.; F. Hoffmann La Roche Ltd. - Overview; F. Hoffmann La Roche Ltd. - Business segments; F. Hoffmann La Roche Ltd. - Key news; F. Hoffmann La Roche Ltd. - Key offerings; F. Hoffmann La Roche Ltd. - Segment focus; 12.11 Fresenius SE and Co. KGaA; Fresenius SE and Co. KGaA - Overview; Fresenius SE and Co. KGaA - Business segments; Fresenius SE and Co. KGaA - Key news; Fresenius SE and Co. KGaA - Key offerings; Fresenius SE and Co. KGaA - Segment focus; 12.12 Gedeon Richter Plc; Gedeon Richter Plc - Overview; Gedeon Richter Plc - Business segments; Gedeon Richter Plc - Key offerings; Gedeon Richter Plc - Segment focus; 12.13 Halozyme Therapeutics Inc.; Halozyme Therapeutics Inc. - Overview; Halozyme Therapeutics Inc. - Product / Service; Halozyme Therapeutics Inc. - Key offerings; 12.14 Intas Pharmaceuticals Ltd.; Intas Pharmaceuticals Ltd. - Overview; Intas Pharmaceuticals Ltd. - Product / Service; Intas Pharmaceuticals Ltd. - Key offerings; 12.15 Mabion S.A.; Mabion S.A. - Overview; Mabion S.A. - Product / Service; Mabion S.A. - Key offerings; 12.16 Novartis AG; Novartis AG - Overview; Novartis AG - Business segments; Novartis AG - Key news; Novartis AG - Key offerings; Novartis AG - Segment focus; 12.17 Viatris Inc.; Viatris Inc. - Overview; Viatris Inc. - Business segments; Viatris Inc. - Key news; Viatris Inc. - Key offerings; Viatris Inc. - Segment focus
13 Appendix: 13.1 Scope of the report; 13.2 Inclusions and exclusions checklist; Inclusions checklist; Exclusions checklist; 13.3 Currency conversion rates for US$; Currency conversion rates for US$; 13.4 Research methodology; Research methodology; 13.5 Data procurement; Information sources; 13.6 Data validation; Data validation; 13.7 Validation techniques employed for market sizing; Validation techniques employed for market sizing; 13.8 Data synthesis; Data synthesis; 360 degree market analysis; 360 degree market analysis; 13.10 List of abbreviations; List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by Product Type; Exhibits6: Executive Summary - Chart on Market Segmentation by Application; Exhibits7: Executive Summary - Chart on Incremental Growth; Exhibits8: Executive Summary - Data Table on Incremental Growth; Exhibits9: Executive Summary - Chart on Company Market Positioning; Exhibits10: Parent Market; Exhibits11: Data Table on - Parent Market; Exhibits12: Market characteristics analysis; Exhibits13: Value Chain Analysis; Exhibits14: Offerings of companies included in the market definition; Exhibits15: Market segments; Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ million); Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ million); Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%); Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%); Exhibits20: Historic Market Size - Data Table on Global Biosimilars Market 2018 - 2022 ($ million); Exhibits21: Historic Market Size - Product Type Segment 2018 - 2022 ($ million); Exhibits22: Historic Market Size - Application Segment 2018 - 2022 ($ million); Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ million); Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ million); Exhibits25: Five forces analysis - Comparison between 2023 and 2028; Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028; Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028; Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028; Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028; Exhibits31: Chart on Market condition - Five forces 2023 and 2028; Exhibits32: Chart on Product Type - Market share 2023-2028 (%); Exhibits33: Data Table on Product Type - Market share 2023-2028 (%); Exhibits34: Chart on Comparison by Product Type; Exhibits35: Data Table on Comparison by Product Type; Exhibits36: Chart on Monoclonal antibodies - Market size and forecast 2023-2028 ($ million); Exhibits37: Data Table on Monoclonal antibodies - Market size and forecast 2023-2028 ($ million); Exhibits38: Chart on Monoclonal antibodies - Year-over-year growth 2023-2028 (%); Exhibits39: Data Table on Monoclonal antibodies - Year-over-year growth 2023-2028 (%); Exhibits40: Chart on Insulin - Market size and forecast 2023-2028 ($ million); Exhibits41: Data Table on Insulin - Market size and forecast 2023-2028 ($ million); Exhibits42: Chart on Insulin - Year-over-year growth 2023-2028 (%); Exhibits43: Data Table on Insulin - Year-over-year growth 2023-2028 (%); Exhibits44: Chart on Human growth hormone - Market size and forecast 2023-2028 ($ million); Exhibits45: Data Table on Human growth hormone - Market size and forecast 2023-2028 ($ million); Exhibits46: Chart on Human growth hormone - Year-over-year growth 2023-2028 (%); Exhibits47: Data Table on Human growth hormone - Year-over-year growth 2023-2028 (%); Exhibits48: Chart on Others - Market size and forecast 2023-2028 ($ million); Exhibits49: Data Table on Others - Market size and forecast 2023-2028 ($ million); Exhibits50: Chart on Others - Year-over-year growth 2023-2028 (%); Exhibits51: Data Table on Others - Year-over-year growth 2023-2028 (%); Exhibits52: Market opportunity by Product Type ($ million); Exhibits53: Data Table on Market opportunity by Product Type ($ million); Exhibits54: Chart on Application - Market share 2023-2028 (%); Exhibits55: Data Table on Application - Market share 2023-2028 (%); Exhibits56: Chart on Comparison by Application; Exhibits57: Data Table on Comparison by Application; Exhibits58: Chart on Oncology and hematology - Market size and forecast 2023-2028 ($ million); Exhibits59: Data Table on Oncology and hematology - Market size and forecast 2023-2028 ($ million); Exhibits60: Chart on Oncology and hematology - Year-over-year growth 2023-2028 (%); Exhibits61: Data Table on Oncology and hematology - Year-over-year growth 2023-2028 (%); Exhibits62: Chart on Endocrinology - Market size and forecast 2023-2028 ($ million); Exhibits63: Data Table on Endocrinology - Market size and forecast 2023-2028 ($ million); Exhibits64: Chart on Endocrinology - Year-over-year growth 2023-2028 (%); Exhibits65: Data Table on Endocrinology - Year-over-year growth 2023-2028 (%); Exhibits66: Chart on Immunology - Market size and forecast 2023-2028 ($ million); Exhibits67: Data Table on Immunology - Market size and forecast 2023-2028 ($ million); Exhibits68: Chart on Immunology - Year-over-year growth 2023-2028 (%); Exhibits69: Data Table on Immunology - Year-over-year growth 2023-2028 (%); Exhibits70: Chart on Nephrology - Market size and forecast 2023-2028 ($ million); Exhibits71: Data Table on Nephrology - Market size and forecast 2023-2028 ($ million); Exhibits72: Chart on Nephrology - Year-over-year growth 2023-2028 (%); Exhibits73: Data Table on Nephrology - Year-over-year growth 2023-2028 (%); Exhibits74: Market opportunity by Application ($ million); Exhibits75: Data Table on Market opportunity by Application ($ million); Exhibits76: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits77: Chart on Market share By Geographical Landscape 2023-2028 (%); Exhibits78: Data Table on Market share By Geographical Landscape 2023-2028 (%); Exhibits79: Chart on Geographic comparison; Exhibits80: Data Table on Geographic comparison; Exhibits81: Chart on Europe - Market size and forecast 2023-2028 ($ million); Exhibits82: Data Table on Europe - Market size and forecast 2023-2028 ($ million); Exhibits83: Chart on Europe - Year-over-year growth 2023-2028 (%); Exhibits84: Data Table on Europe - Year-over-year growth 2023-2028 (%); Exhibits85: Chart on North America - Market size and forecast 2023-2028 ($ million); Exhibits86: Data Table on North America - Market size and forecast 2023-2028 ($ million); Exhibits87: Chart on North America - Year-over-year growth 2023-2028 (%); Exhibits88: Data Table on North America - Year-over-year growth 2023-2028 (%); Exhibits89: Chart on Asia - Market size and forecast 2023-2028 ($ million); Exhibits90: Data Table on Asia - Market size and forecast 2023-2028 ($ million); Exhibits91: Chart on Asia - Year-over-year growth 2023-2028 (%); Exhibits92: Data Table on Asia - Year-over-year growth 2023-2028 (%); Exhibits93: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits94: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits95: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits96: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits97: Chart on Germany - Market size and forecast 2023-2028 ($ million); Exhibits98: Data Table on Germany - Market size and forecast 2023-2028 ($ million); Exhibits99: Chart on Germany - Year-over-year growth 2023-2028 (%); Exhibits100: Data Table on Germany - Year-over-year growth 2023-2028 (%); Exhibits101: Chart on US - Market size and forecast 2023-2028 ($ million); Exhibits102: Data Table on US - Market size and forecast 2023-2028 ($ million); Exhibits103: Chart on US - Year-over-year growth 2023-2028 (%); Exhibits104: Data Table on US - Year-over-year growth 2023-2028 (%); Exhibits105: Chart on UK - Market size and forecast 2023-2028 ($ million); Exhibits106: Data Table on UK - Market size and forecast 2023-2028 ($ million); Exhibits107: Chart on UK - Year-over-year growth 2023-2028 (%); Exhibits108: Data Table on UK - Year-over-year growth 2023-2028 (%); Exhibits109: Chart on China - Market size and forecast 2023-2028 ($ million); Exhibits110: Data Table on China - Market size and forecast 2023-2028 ($ million); Exhibits111: Chart on China - Year-over-year growth 2023-2028 (%); Exhibits112: Data Table on China - Year-over-year growth 2023-2028 (%); Exhibits113: Chart on Republic of Korea - Market size and forecast 2023-2028 ($ million); Exhibits114: Data Table on Republic of Korea - Market size and forecast 2023-2028 ($ million); Exhibits115: Chart on Republic of Korea - Year-over-year growth 2023-2028 (%); Exhibits116: Data Table on Republic of Korea - Year-over-year growth 2023-2028 (%); Exhibits117: Market opportunity By Geographical Landscape ($ million); Exhibits118: Data Tables on Market opportunity By Geographical Landscape ($ million); Exhibits119: Impact of drivers and challenges in 2023 and 2028; Exhibits120: Overview on criticality of inputs and factors of differentiation; Exhibits121: Overview on factors of disruption; Exhibits122: Impact of key risks on business; Exhibits123: Companies covered; Exhibits124: Matrix on companies position and classification; Exhibits125: AbbVie Inc. - Overview; Exhibits126: AbbVie Inc. - Product / Service; Exhibits127: AbbVie Inc. - Key news; Exhibits128: AbbVie Inc. - Key offerings; Exhibits129: Amgen Inc. - Overview; Exhibits130: Amgen Inc. - Product / Service; Exhibits131: Amgen Inc. - Key news; Exhibits132: Amgen Inc. - Key offerings; Exhibits133: Biocon Ltd. - Overview; Exhibits134: Biocon Ltd. - Business segments; Exhibits135: Biocon Ltd. - Key offerings; Exhibits136: Biocon Ltd. - Segment focus; Exhibits137: Biogen Inc. - Overview; Exhibits138: Biogen Inc. - Product / Service; Exhibits139: Biogen Inc. - Key news; Exhibits140: Biogen Inc. - Key offerings; Exhibits141: Boehringer Ingelheim International GmbH - Overview; Exhibits142: Boehringer Ingelheim International GmbH - Product / Service; Exhibits143: Boehringer Ingelheim International GmbH - Key news; Exhibits144: Boehringer Ingelheim International GmbH - Key offerings; Exhibits145: Celltrion Healthcare Co. Ltd. - Overview; Exhibits146: Celltrion Healthcare Co. Ltd. - Product / Service; Exhibits147: Celltrion Healthcare Co. Ltd. - Key offerings; Exhibits148: Dr Reddys Laboratories Ltd. - Overview; Exhibits149: Dr Reddys Laboratories Ltd. - Business segments; Exhibits150: Dr Reddys Laboratories Ltd. - Key news; Exhibits151: Dr Reddys Laboratories Ltd. - Key offerings; Exhibits152: Dr Reddys Laboratories Ltd. - Segment focus; Exhibits153: F. Hoffmann La Roche Ltd. - Overview; Exhibits154: F. Hoffmann La Roche Ltd. - Business segments; Exhibits155: F. Hoffmann La Roche Ltd. - Key news; Exhibits156: F. Hoffmann La Roche Ltd. - Key offerings; Exhibits157: F. Hoffmann La Roche Ltd. - Segment focus; Exhibits158: Fresenius SE and Co. KGaA - Overview; Exhibits159: Fresenius SE and Co. KGaA - Business segments; Exhibits160: Fresenius SE and Co. KGaA - Key news; Exhibits161: Fresenius SE and Co. KGaA - Key offerings; Exhibits162: Fresenius SE and Co. KGaA - Segment focus; Exhibits163: Gedeon Richter Plc - Overview; Exhibits164: Gedeon Richter Plc - Business segments; Exhibits165: Gedeon Richter Plc - Key offerings; Exhibits166: Gedeon Richter Plc - Segment focus; Exhibits167: Halozyme Therapeutics Inc. - Overview; Exhibits168: Halozyme Therapeutics Inc. - Product / Service; Exhibits169: Halozyme Therapeutics Inc. - Key offerings; Exhibits170: Intas Pharmaceuticals Ltd. - Overview; Exhibits171: Intas Pharmaceuticals Ltd. - Product / Service; Exhibits172: Intas Pharmaceuticals Ltd. - Key offerings; Exhibits173: Mabion S.A. - Overview; Exhibits174: Mabion S.A. - Product / Service; Exhibits175: Mabion S.A. - Key offerings; Exhibits176: Novartis AG - Overview; Exhibits177: Novartis AG - Business segments; Exhibits178: Novartis AG - Key news; Exhibits179: Novartis AG - Key offerings; Exhibits180: Novartis AG - Segment focus; Exhibits181: Viatris Inc. - Overview; Exhibits182: Viatris Inc. - Business segments; Exhibits183: Viatris Inc. - Key news; Exhibits184: Viatris Inc. - Key offerings; Exhibits185: Viatris Inc. - Segment focus; Exhibits186: Inclusions checklist; Exhibits187: Exclusions checklist; Exhibits188: Currency conversion rates for US$; Exhibits189: Research methodology; Exhibits190: Information sources; Exhibits191: Data validation; Exhibits192: Validation techniques employed for market sizing; Exhibits193: Data synthesis; Exhibits194: 360 degree market analysis; Exhibits195: List of abbreviations